A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout of the commercial-scale plant.
Categories:
Related Post
ICE raids leave future of construction labor in limbo
Increased immigration enforcement on jobsites has led to more callouts and potentially longer project timelines, but experts believe…
Can cities and states keep their roads in good shape?
With an influx of pandemic-era funds already spent, many states anticipate funding gaps over the…
NAHB: Multifamily completions hit 38-year high
The South accounted for 48% of deliveries in 2024, followed by the West at 27%.